Recent studies have shown that calcium-activated chloride channels (CLCAs) are expressed in various non-nervous organs or tissues, including cardiac muscle, 1,2) epithelium,
smooth muscle, 4, 5) exocrine gland cells 6) and Xenopus oocytes. 7) The CLCAs, which open in response to the increased [Ca 2ϩ ] i triggered by Ca 2ϩ influx during electrical excitation or G-protein coupled receptor activation, play important physiological roles, including maintenance of smooth muscle tone, secretion of transepithelial fluid, regulation of cell volume, maintenance of cardiac potential, and fast blockade of polyspermy. 8) CLCAs have been identified in a number of peripheral and central neuron populations, including the sensory cilia of olfactory neurons, where they are involved in generating the receptor current during odor detection. 9) However, the encoding genes and physiological functions of other CLCAs in the nervous system still remain to be investigated.
We previously reported the cloning and functional expression of a CLCA from rat brain (rbCLCA; rat brain CLCA) that was 84.3% identical to mCLCA4, 13) and showed that this rbCLCA, which we renamed rbCLCA1, 10) which was responsible for the calcium-activated chloride current in the rat cerebrum. 13) Here, we report the cloning and functional expression of a second rat brain CLCA, which we designated rbCLCA2. Similar to the other CLCA genes, rbCLCA2 shows high homology to other family members (e.g., 85 .5% identity to rbCLCA1 10) ) and is expressed in nervous and nonnervous tissues. Transient transfection of HEK293 cells with an expression vector encoding rbCLCA2 led to expression of calcium-activated currents similar to those observed in rb-CLCA1-expressing cells, further suggesting that rbCLCA2 might represent a second calcium-activated chloride channel from rat brain and other organs. RNA Extraction Total RNA was extracted from various rat tissues using the easy-BLUE TM reagent (iNtRON) as previously described. 10) To avoid genomic DNA contamination, the extracted total RNA samples were digested with RNasefree DNase I (Invitrogen) prior to use.
MATERIALS AND METHODS

Materials
Cloning of the Full-Length cDNA Rat brain RNA (10 mg) was reverse transcribed with Superscript III reverse transcriptase (Invitrogen) for generation of first strand cDNA. For rapid amplification of cDNA ends (RACE), first strand synthesis was performed in the presence of a genespecific primer for 5Ј-RACE or an oligo-dT primer for 3Ј- We previously reported the cloning of a calcium-activated chloride channel (CLCA) from rat brain (Biochem. Biophys. Res. Commun., 334, 569-576 (2005)), which we designated rbCLCA1. We further showed that rbCLCA1 is expressed in the central nervous system and peripheral organs, and may be functionally expressed in mammalian HEK293 cells. In the present study, we report the successful cloning of a second CLCA from rat cerebrum (designated rbCLCA2), using reverse transcription-PCR (RT-PCR) with primers specific for rbCLCA1. We have begun to clone this cDNA based on the rbCLCA1-like sequence. The full-length rbCLCA2 cDNA, obtained via 5 and 3 rapid amplification of cDNA ends (RACE), is 2900 bp long and encodes a putative polypeptide of 905 amino acids having at least two major transmembrane domains and showing 85.2% identity to rbCLCA1. RT-PCR analysis revealed that, similar to rbCLCA1, rbCLCA2 was predominantly expressed in the rat cerebrum, cerebellum, kidney, stomach, spinal cord, lung and small intestine, but not in the heart, large intestine, liver, orand spleen. Whole-cell patch clamp studies in HEK293 cells transiently co-transfected with expression vectors encoding rbCLCA2 and EGFP allowed us to identify the presence of niflumic acid (a CLCA channel blocker)-sensitive and voltage-dependent chloride currents in cells expressing rbCLCA2 but not EGFP alone. Treatment of these cells with ionomycin, a Ca 2؉ ionophore, significantly increased the novel currents in cells expressing rbCLCA2 and EGFP, but not those expressing EGFP alone, indicating that activation of the rb-CLCA2 current is Ca 2؉ -dependent. In sum, we herein report the cloning of a second member of the rbCLCA family from rat brain and its functional expression in vitro, thus adding to our knowledge of anion channels and facilitating future exploration of brain and other organ physiology.
RACE. The obtained 3Ј and 5Ј cDNA products are shown in Fig. 1 . To obtain the full-length cDNA, PCR was carried out with several primer sets specific for rbCLCA1 and rb-CLCA2, using KOD-Plus Taq polymerase (Toyobo). The amplified PCR products were sequenced as described below, and the resulting sequences were used to design rbCLCA2-specific primers for amplification using nested PCR and the following conditions: first round, 25 cycles of 94°C for 20 s, 57.5-60°C for 30 s, and 68°C for 1-2 min 30 s; second round, 25-30 cycles of 94°C for 30 s, 58-62.5°C for 30 s, and 68°C for 1-2 min 30 s (Fig. 1) . The full-length cDNA was obtained following several rounds of this 'walking out' procedure.
Reverse Transcription-PCR (RT-PCR) First strand cDNA was generated from various rat tissues as described above, and gene-specific amplification was performed with two rounds of nested PCR using i-StarTaq TM polymerase (iNtRON) and the primers listed in Table 1 . The first round of PCR was performed with gene-specific primers and the following amplification conditions: 94°C for 1 min, followed by 25 cycles of 94°C for 15 s, 60°C for 30 s and 72°C for 40 s. The amplified PCR products were purified using a PROBER TM Probe DNA purifying system (iNtRON Biotechnology), and then 1/50 of each PCR product was subjected to a second round of amplification using nested primers and the following conditions: 94°C for 1 min, followed by 30 cycles of 94°C for 15 s, 60°C for 30 s and 72°C for 30 s.
Gel Documentation and Semi-quantification RT-PCR products were electrophoresed on a 2% agarose gel. The amplified DNA bands were visualized by ethidium bromide staining, and then quantified densitometrically using a computer-assisted imaging system, Bio-1D software (Vilver Lourmat, La Vallee-Cedex 1, France).
Sequencing and Analysis PCR products were poly-A tailed, and then inserted into the TA cloning vector, pGEM-T Easy (Promega) for amplification and nucleotide sequencing on an ABI PRISM system (model 377). Homology searches were performed on the BLAST server.
Cell Culture and Plasmid Construction Human embryonic kidney (HEK) 293 cells were cultured in minimum essential medium supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate, 0.1 mM non-essential amino acid solution, 100 units/ml penicillin G sodium, 100 mg/ml streptomycin sulfate and 400 mg/ml geneticin (G418) in an atmosphere of 95% air and 5% CO 2 . At 60-80% confluence, cells were treated with media containing 0.25% trypsin and 0.02% EDTA for 3 min, washed with fresh media, and dispensed to new plastic culture dishes. The full-length rb-CLCA2 cDNA was amplified from the full length of cDNA as described in Materials and Methods using KOD-Plus Taq polymerase and the BamHI and EcoRI site-attached RC40 and RC41 primers, 10) respectively. The amplified fragment was digested with the appropriate restriction enzymes and directionally inserted downstream of the CMV promoter in the pcDNA 3.1 ϩ expression vector (Invitrogen). Correct insertion was confirmed by sequencing, and plasmids were prepared for transfection using the plasmid maxi kit (QIAGEN).
Heterologous Expression of rbCLCA2 in HEK293 Cells HEK293 cells were transfected with an EGFP-encoding vector alone (100 ng) or co-transfected with EGFP-encoding plasmids and rbCLCA2-encoding plasmids at a 10 : 1 ratio (1 mg of DNA total), using Lipofectamine 2000 (Invitrogen). After incubation for 2 d, cells were dissociated and seeded onto 5 mm glass coverslips. After 5-24 h of incubation in 24-well plates, the cultured cells were transferred to the recording chamber, and fluorescent cells were used for patch-clamp experiments within 4 d.
Whole-Cell Recordings Whole-cell currents were recorded using patch-clamp techniques under a fluorescence microscope. The external bath solution contained 112 mM NMDG · Cl, 30 mM sucrose, 2 mM CaCl 2 , 2 mM MgCl 2 and 5 mM HEPES, and was adjusted to pH 7.4 with HCl. The intracellular pipette solution was the same as the external bath solution except that it contained 100 mM CaCl 2 and 5 mM Mg · ATP. For ionomycin experiments, the intracellular pipette solution contained 1 mM ethylene glycol-bis(2-aminoethylether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA) instead of 100 mM CaCl 2 . Niflumic acid (NFA) (Sigma) was prepared in DMSO stock solution (100 mM) and stored at Ϫ20°C until use. The patch pipettes had resistances of 2-4 MW in the external bath solutions. All ionic currents were recorded using EPC10 amplifiers (HEKA Electronic, Lambrecht- Pfalz, Germany). The Pulse computer program (HEKA Electronic) was used for voltage-clamp amplifier control, data acquisition and analysis. The current signals were filtered with a 5 kHz analog 3-pole Bessel filter. The sampling frequency was set at 10 kHz. Solutions were applied to the HEK293 cells by continuous perfusion of the chamber during recording. All experiments were performed at 36Ϯ1°C.
RESULTS AND DISCUSSION
In the present study, we cloned a second rat brain CLCA utilizing the previously reported rbCLCA1 sequence 10) as a starting point. RT-PCR using primers based on the rbCLCA1 sequence allowed us to isolate a homologous fragment from rat brain cDNA, and RACE allowed us to successfully clone the full-length coding sequence of this new gene, which we designated rbCLCA2. Sequence analysis of the full-length cDNA (2900 bp; Genbank No. AB256513) revealed a single large open reading frame, along with short 5Ј and 3Ј-untranslated sequences (UTRs). The 3Ј-UTR was followed by a poly(A) ϩ tail, and a polyadenylation signal-like sequence (ATTAAA) was found 16-21 bases upstream of the poly(A) ϩ tail. The putative protein deduced from the coding sequence consists of 905 amino acids, and shows high homology to rbCLCA1, as well as the mouse [11] [12] [13] and human CLCA proteins. Notably, the predicted rbCLCA2 protein is 52.8, 47.4, 75.2 and 51.3% identical to human CLCA1, 2, 3 and 4, respectively, and 77.2, 77.5, 49.7, 84.7, 45.7 and 48.8% identical to mCLCA1, 2, 3, 4, 5 and 6, respectively. Although hCLCA3 (NM_004921) is the short precursor, it shows the very highest homology (75.2%) among the human CLCA family. The predicted rbCLCA2 protein sequence was highly homologous to mCLCA1 and mCLCA2, but differed at the carboxyl terminus (data not shown), whereas rb-CLCA2 was highly homologous (84.7%) to the entire protein sequence of mCLCA4, including the C-terminus.
13) The amino acid sequence of the rbCLCA2 C-terminus was most significantly homologous to that of rbCLCA1 from rat brain 10) ; indeed, these two proteins were highly similar, showing 85.5% identity throughout their sequences ( Fig.  2A) . Motif analysis revealed that, similar to rbCLCA1, the putative rbCLCA2 sequence contains sites for signal peptidase cleavage, N-linked glycosylation, and phosphorylation by PKC, cAMP-and cGMP-dependent protein kinases, as well as tyrosine kinase and casein kinase II (Fig. 2A) . Hydropathy analysis of the full-length rbCLCA2 open reading frame using an analysis window of 17 residues revealed two major potential transmembrane-spanning domains as well as several minor regions, which differs slightly from the four spanning regions predicted in rbCLCA1, 10) but is generally consistent with rbCLCA2 being a membrane protein (Fig.  2B) .
To examine the tissue expression patterns of rbCLCA2, we performed the 55 repeats of RT-PCR in different rat tissue samples, including cerebrum, cerebellum, spinal cord, heart, lung, stomach, liver, spleen, kidney, small intestine and large intestine. An amplified rbCLCA2-specific band of the expected size (445 bp) was observed in kidney, stomach, cerebrum, cerebellum, spinal cord, small intestine and lung, but not in heart, liver, spleen and large intestine, whereas the positive/loading control (b-actin, 488 bp) was clearly ob- served in all tissues (Figs. 3A, B) . Thus, in contrast to rb-CLCA1, which was mainly expressed in the cerebrum and cerebellum, 10) rbCLCA2 was more highly expressed in the rat kidney, stomach and nervous system tissues.
We then sought to characterize rbCLCA2 through its functional expression in HEK293 cells. Cells were transfected with plasmids encoding EGFP or co-transfected with plasmids encoding EGFP and rbCLCA2, and whole-cell recordings were used to examine de novo currents. Cells were subjected to voltage steps in 20 mV increments from Ϫ80 to 80 mV at a holding potential of Ϫ70 mV with 100 mM CaCl 2 in the pipette. Our results revealed minimal current in cells transfected with EGFP alone, whereas we observed a large current in EGFPϩrbCLCA2 co-transfected cells (Fig. 4) ; specifically, the mean current amplitudes at 80 mV were 157.7Ϯ6.8 pA in rbCLCA2ϩEGFP cotransfected cells (nϭ10, five different batches of cells), but only 9.1Ϯ5.1 pA (nϭ6) in cells expressing EGFP alone (pϽ0.001, non-paired t-test) (Fig. 4B) . The bath and pipette solutions contained mostly NMDG · Cl with small amounts of CaCl 2 and MgCl 2 , meaning that chloride ion was the major ion species comprising the current, which showed voltage dependence and a slightly outwardly rectifying current (Fig. 4C) .
To examine whether the heterologously expressed rb-CLCA2 in HEK293 cells is Ca 2ϩ -activated Cl Ϫ channel, we tested the effect of niflumic acid, a blocker of the endogenous Ca 2ϩ -activated Cl Ϫ current in Xenopus oocytes. 14) In the presence of 100 mM niflumic acid, the Cl Ϫ current induced by rbCLCA2ϩEGFP cotransfection was slightly blocked (data not shown), whereas 300 mM niflumic acid blocked about 50Ϯ6.5% of the current induced by rbCLCA2ϩEGFP cotransfection (nϭ6-8) (Fig. 4C) .
To test Ca 2ϩ ion sensitivity, we replaced the 100 mM CaCl 2 in the pipette solution with 1 mM EGTA (to minimize the cur- (Fig. 5 ). Cells transfected with EGFP alone showed little current change following either treatment (Fig. 5A) . In contrast, the change in pipette solution decreased the current in rbCLCA2ϩEGFP co-transfected cells to Ͻ20 pA, whereas addition of 0.2 mM ionomycin increased the current by 411Ϯ57.8% (nϭ7) at 80 mV (Fig. 5B) . These results indicate that activation of the heterologously expressed rbCLCA2 current is Ca 2ϩ -dependent. The Cl Ϫ channels comprise a large and diverse group including four major types.
8) The voltage-dependent Cl Ϫ channels, encoded by the ClC gene family, each have twelve transmembrane domains but vary greatly in terms of tissue expression patterns.
9) The ligand-gated chloride channels, including the glycine and GABA A receptors, typically have four transmembrane domains, are expressed in the nervous system, and are assembled into functional pentamers.
9) The cAMP-regulated Cl Ϫ channel family has a single member, the cystic fibrosis transmembrane conductance regulator (CFTR), which harbors a nonfunctional mutation in individuals affected with cystic fibrosis. [15] [16] [17] The fourth and final type of Cl Ϫ channel is the calcium-activated chloride channel (CLCA) family. 18) Previous studies have noted that some CLCA isoforms are deficient or down-regulated in breast cancer cell lines and colorectal carcinoma cells, suggesting that these CLCA subtypes may also be also involved in tumor suppression or promotion of tumor cell apoptosis. [20] [21] [22] However, the channel properties and physiological roles of the CLCAs are still somewhat controversial, largely due to the lack of selective and specific CLCA antagonists, and minimal knowledge of their molecular targets. 19) The characteristic hallmark of a CLCA current is activation by cytosolic Ca 2ϩ elevation, which can be experimentally induced by stimulating cells with Ca Here, we report the cloning and functional expression of a second CLCA family member from rat brain. This CLCA, rbCLCA2, shows 85.5% homology to the previously reported rat brain CLCA, rbCLCA1. 10) We further found that both rbCLCAs are strongly expressed in kidney, stomach, cerebrum, cerebellum and small intestine, but are only weakly expressed in the large intestine, lung, liver and spleen. Interestingly, we did not observe expression of either CLCAs in the heart, even though this organ is known to possess endogenous CLCAs (Fig. 3) . 1, 2) Using HEK293 cells, we successfully expressed functional rbCLCA2, as shown by observation of currents in rbCLCA2ϩEGFP co-transfected cells but not in cells transfected with EGFP alone. The Ca 2ϩ ionophore, ionomycin, increased the observed currents in rbCLCA2ϩEGFP co-transfected cells but not in cells transfected with EGFP alone, and the currents evoked when the pipette solution contained Ca 2ϩ were significantly inhibited by niflumic acid, a Cl Ϫ channel blocker. Interestingly, only a slight inhibition of Cl Ϫ current was observed when cells were treated with 100 mM niflumic acid (data not shown), but treatment with 300 mM niflumic acid blocked the Cl Ϫ current by 50Ϯ6.5% (Fig. 4B) . Consistent with this finding, we previously reported that treatment of 300 but not 100 mM NFA induced a large inhibition of the heterologously expressed rbCLCA1 currents. 10) These results indicate that both rbCLCA1 and rbCLCA2 might be less sensitive to NFA compared with other types of CLCAs as shown in a previous report. 23) In summary, we herein have reported the cloning and functional expression of a new Ca 2ϩ -activated Cl Ϫ channel from rat brain that shares high homology with the previously reported rbCLCA1 (85.5%). Our findings indicate that organs such as rat brain, kidney, stomach, small intestine, and lung express at least two types of CLCA. Future studies will be required to further elucidate the physiological and/or pharmacological roles of these channels in the brain and other organs. The membrane voltage was held at Ϫ70 mV and a step-pulse protocol was applied, with currents normalized to those obtained at 80 mV before ionomycin treatment. (A) Currents obtained before or 2 min after treatment with 0.2 mM ionomycin in cells expressing EGFP alone (nϭ5; ᭺, before ionomycin treatment; ᭹, 2 min after ionomycin treatment). The percentage of the CLCA current remaining at 80 mV in ionomycin was 99.2Ϯ9.5%. (B) Currents obtained before or 2 min after treatment with 0.2 mM ionomycin in cells expressing rbCLCA2ϩEGFP (nϭ7; ᭺, before ionomycin treatment; ᭹, 2 min after ionomycin treatment) ( * pϽ0.05, * * pϽ0.01, * * * pϽ0.001, unpaired t-test).
